|
Originally published In Press as doi:10.1194/jlr.M400240-JLR200 on September 1, 2004
Journal of Lipid Research, Vol. 45, 2138-2144, November 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology
Fatty acid binding proteins stabilize leukotriene A4
:
competition with arachidonic acid but not other lipoxygenase products
Jennifer S. Dickinson Zimmer*, ,
Douglas F. Dyckes ,
David A. Bernlohr** and
Robert C. Murphy1,*,
* Department of Pharmacology, University of Colorado Health Sciences Center, Aurora, CO 80045
Division of Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206
Department of Chemistry, University of Colorado at Denver, Denver, CO 80217
** Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN 55455
1 To whom correspondence should be addressed. e-mail: robert.murphy{at}uchsc.edu
Leukotriene A4 (LTA4) is a chemically reactive conjugated triene epoxide product derived from 5-lipoxygenase oxygenation of arachidonic acid. At physiological pH, this reactive compound has a half-life of less than 3 s at 37°C and 40 s at 4°C. Regardless of this aqueous instability, LTA4 is an intermediate in the formation of biologically active leukotrienes, which can be formed through either intracellular or transcellular biosynthesis. Previously, epithelial fatty acid binding protein (E-FABP) present in RBL-1 cells was shown to increase the half-life of LTA4 to 20 min at 4°C. Five FABPs (adipocyte FABP, intestinal FABP, E-FABP, heart/muscle FABP, and liver FABP) have now been examined and also found to increase the half-life of LTA4 at 4°C to 20 min with protein present. Stabilization of LTA4 was examined when arachidonic acid was present to compete with LTA4 for the binding site on E-FABP. Arachidonate has an apparent higher affinity for E-FABP than LTA4 and was able to completely block stabilization of the latter. When E-FABP is not saturated with arachidonate, FABP can still stabilize LTA4.
Several lipoxygenase products, including 5-hydroxyeicosatetraenoic acid, 5,6-dihydroxyeicosatetraenoic acid, and leukotriene B4, were found to have no effect on the stability of LTA4 induced by E-FABP even when present at concentrations 3-fold higher than LTA4.
Abbreviations: cPLA2, cytosolic phospholipase A2; diHETE, dihydroxyeicosatetraenoic acid; EET, epoxyeicosatrienoic acid; FABP, fatty acid binding protein; FLAP, 5-lipoxygenase-activating protein; HETE, hydroxyeicosatetraenoic acid; HpETE, hydroperoxyeicosatetraenoic acid; LTA4, leukotriene A4; LTB4, leukotriene B4; TEA, triethylamine; 5-LO, 5-lipoxygenase Supplementary key words half-life transcellular biosynthesis leukotriene biosynthesis

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. L. Rector and R. C. Murphy
Determination of leukotriene A4 stabilization by S100A8/A9 proteins using mass spectrometry
J. Lipid Res.,
October 1, 2009;
50(10):
2064 - 2071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Gijon, S. Zarini, and R. C. Murphy
Biosynthesis of eicosanoids and transcellular metabolism of leukotrienes in murine bone marrow cells
J. Lipid Res.,
March 1, 2007;
48(3):
716 - 725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Folco and R. C. Murphy
Eicosanoid Transcellular Biosynthesis: From Cell-Cell Interactions to in Vivo Tissue Responses
Pharmacol. Rev.,
September 1, 2006;
58(3):
375 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Cao, K. Maeda, C. Z. Gorgun, H.-J. Kim, S.-Y. Park, G. I. Shulman, J. K. Kim, and G. S. Hotamisligil
Regulation of metabolic responses by adipocyte/ macrophage Fatty Acid-binding proteins in leptin-deficient mice.
Diabetes,
July 1, 2006;
55(7):
1915 - 1922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Xu, Y. Wang, J. Y. Xu, D. Stejskal, S. Tam, J. Zhang, N. M.S. Wat, W. K. Wong, and K. S.L. Lam
Adipocyte Fatty Acid-Binding Protein Is a Plasma Biomarker Closely Associated with Obesity and Metabolic Syndrome
Clin. Chem.,
March 1, 2006;
52(3):
405 - 413.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|